Freedom Investment Management, Inc. - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$241,132
-25.7%
17,941
-8.3%
0.03%
-27.0%
Q1 2023$324,478
-16.1%
19,570
-5.9%
0.04%
-15.9%
Q4 2022$386,939
-99.9%
20,803
+1.6%
0.04%
+46.7%
Q3 2022$262,763,000
+98.3%
20,480
+8.4%
0.03%
+114.3%
Q2 2022$132,495,00018,9010.01%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 589,883$590,0001.38%
Broadfin Capital, LLC 8,200,000$8,610,0000.96%
Avoro Capital Advisors LLC 1,141,149$1,198,0000.24%
CORRADO ADVISORS, LLC 190,600$200,0000.12%
Baker Brothers Advisors 5,102,153$5,357,0000.05%
KINGDON CAPITAL MANAGEMENT, L.L.C. 756,311$794,0000.04%
Point72 Asset Management, L.P. 2,272,816$2,386,0000.02%
AGRAN LIBBIE 44,000$46,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 10,000$11,0000.01%
KENNEDY CAPITAL MANAGEMENT LLC 233,171$245,0000.00%
View complete list of CATALYST PHARMACEUTICALS INC shareholders